References
Buecher, B., Cacheux, W., Rouleau, E., Dieumegard, B., Mitry, E., & Lièvre, A. (2013). Role of microsatellite instability in the management of colorectal cancers. Digestive and Liver Disease, 45, 441-449. doi:10.1016/j.dld.2012.10.006
Burt, R.W., Cannon, J.A., David, D.S., Early, D.S., Ford, J.M., Giardiello, F.M., … Freedman-Cass, D. (2013). Colorectal cancer screening. Journal of the National Comprehensive Cancer Network, 11, 1538-1575.
Gala, M., & Chung, D.C. (2011). Hereditary colon cancer syndromes. Seminars in Oncology, 38, 490-499.
Gibson, J., Lacy, J., Matloff, E., & Robert, M. (2014). Microsatellite instability testing in colorectal carcinoma: A practical guide. Clinical Gastroenterology and Hepatology, 12, 171-176.
Hall, M.J. (2010). Counterpoint: Implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients—Will the ends justify the means? Journal of the National Comprehensive Cancer Network, 8, 606-611.
Hampel, H. (2010). Point: Justification for Lynch Syndrome screening among all patients with newly diagnosed colorectal cancer. Journal of the National Comprehensive Cancer Network, 8, 597-601.
Kalady, M.F. (2013). Sessile serrated polyps: An important route to colorectal cancer. Journal of the National Comprehensive Cancer Network, 11, 1585-1594.
Kelley, R.K., Van Bebber, S.L., Phillips, K.A., & Venook, A.P. (2011). Personalized medicine and oncology practice guidelines: A case study of contemporary biomarkers in colorectal cancer. Journal of the National Comprehensive Cancer Network, 9, 13-25.
Kloor, M., Staffa, L., Ahadova, A., & von Knebel Doeberitz, M. (2014). Clinical significance of microsatellite instability in colorectal cancer. Langenbeck's Archives of Surgery, 399(1), 23-31. doi:10.1007/s00423-013-1112-3
Matloff, J., Lucas, A., Polydorides, A.D., & Itzkowitz, S.H. (2013). Molecular tumor testing for Lynch syndrome in patients with colorectal cancer. Journal of the National Comprehensive Cancer Network, 11, 1380-1385.
Meguerditchian, A.N., & Bullard Dunn, K. (2013). Biomarkers and targeted therapeutics in colorectal cancer. Surgical Oncology Clinics of North America, 22, 841-855. doi:10.1016/j.soc.2013.07.002
Power, D.G., Gloglowski, E., & Lipkin, S.M. (2010). Clinical genetics of hereditary colorectal cancer. Hematology/Oncology Clinics of North America, 24, 837-859.
Rosner, G., & Strul, H. (2014). Should microsatellite instability be tested in all cases of colorectal cancer? Current Colorectal Cancer Reports, 10, 27-35. doi:10.1007/s11888-013-0204-3
Senter, L. (2012). Genetic testing by cancer site: Colon (nonpolyposis syndromes). Cancer Journal, 18, 334-337.
Serrano, M., Lage, P., Belga, S., Filipe, B., Francisco, I., Rodrigues, P., … Pereira, A.D. (2012). Bethesda criteria for microsatellite instability testing: Impact on the detection of new cases of Lynch syndrome. Familial Cancer, 11, 571-578.
Umar, A., Boland, C.R., Terdiman, J.P., Syngal, S., de la Chapelle, A., Rüschoff, J., … Srivastava, S. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute, 96, 261-268.
Weissman, S.M., Burt, R., Church, J., Erdman, S., Hampel, H., Holter, S., … Senter, L. (2012). Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. Journal of Genetic Counseling, 21, 484-493. doi:10.1007/s10897-011-9465-7